The report "Bioburden Testing Market by Product (Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)), Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the bioburden testing market along with estimates and forecasts of the revenue and share analysis.

Browse 96 market data tables and 46 figures spread through 180 pages and in-depth TOC on “Bioburden Testing Market"http://www.marketsandmarkets.com/Market-Reports/bioburden-testing-market-17983056.htmlEarly buyers will receive 10% customization on this report.

The global bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019.

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=17983056

The report segments the bioburden testing market on the basis of products and services, test types, applications, end users, and regions. In the product segment, consumables accounted for the largest share in 2014; however, the culture media and reagents & kits segment will grow at the highest CAGR during the forecast period as culture media and reagents & kits are most commonly used for bioburden testing. Factors such as the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the bioburden testing market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination are driving the growth of the bioburden testing market.

Based on regions, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in the forecast period.

You can speak To Research Analyst to know more about Report: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=17983056

Key players in the bioburden testing market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co. Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).

Browse Related Reports:Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 2019.http://www.marketsandmarkets.com/Market-Reports/biologics-safety-testing-market-34624144.html

Microbial Identification Market by Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages) & by End User (Detection, Characterization) - Global Forecasts to 2019.http://www.marketsandmarkets.com/Market-Reports/microbial-identification-market-10702182.html

About MarketsandMarkets:MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:Mr. RohanNorth - Dominion Plaza,17304, Preston Road,Suite 800, Dallas, TX 75252Tel: +1-888-600-6441Email: sales@marketsandmarkets.comVisit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnologyConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets